Mylan Inc. (Nasdaq: MYL) is buying Agila Specialties Private Ltd., a company that develops generic injectable products for $1.85 billion.

Strides Arcolab Ltd. (BSE: 532531) currently owns Agila, headquartered in Bengaluru, India. The price tag amounts to about $1.6 billion in cash at closing and up to $250 million in additional cash, should Strides meet certain unspecified conditions.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.